Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


20.05.2019

2 Am J Gastroenterol
3 BMC Gastroenterol
2 Clin Infect Dis
1 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
2 Gastroenterology
1 Gut
2 Hepatology
5 J Hepatol
1 J Med Virol
7 J Viral Hepat
2 J Virol
1 JAMA
2 PLoS One
1 PLoS Pathog
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. BZOWEJ NH, Tran TT, Li R, Belle SH, et al
    Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
    Am J Gastroenterol. 2019 May 1. doi: 10.14309/ajg.0000000000000221.
    PubMed     Text format     Abstract available

  2. PEARLMAN B, Perrys M, Hinds A
    Sofosbuvir/Velpatasvir/Voxilaprevir for Previous Treatment Failures With Glecaprevir/Pibrentasvir in Chronic Hepatitis C Infection.
    Am J Gastroenterol. 2019 May 8. doi: 10.14309/ajg.0000000000000248.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  3. DESALEGN H, Aberra H, Berhe N, Medhin G, et al
    Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study.
    BMC Gastroenterol. 2019;19:74.
    PubMed     Text format     Abstract available

  4. LIU Y, Jiang M, Xue J, Yan H, et al
    Correction to: Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection.
    BMC Gastroenterol. 2019;19:72.
    PubMed     Text format     Abstract available

  5. SUN J, Ding H, Chen G, Wang G, et al
    Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China.
    BMC Gastroenterol. 2019;19:65.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  6. GUTKIND S, Schackman BR, Morgan JR, Leff JA, et al
    Cost-effectiveness of HCV Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs.
    Clin Infect Dis. 2019 May 16. pii: 5490664. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. ASSOUMOU SA, Tasillo A, Vellozzi C, Yazdi GE, et al
    Cost-effectiveness and budgetary impact of HCV testing, treatment and linkage to care in U.S. prisons.
    Clin Infect Dis. 2019 May 16. pii: 5490662. doi: 10.1093.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  8. LEY D, Hayney MS, Caldera F
    Third Time's a Charm: Immunization Strategies for Hepatitis B in Immunosuppressed Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 May 11. pii: 10.1007/s10620-019-05662.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  9. TADA T, Toyoda H, Yasuda S, Miyake N, et al
    Long-term prognosis of liver disease in patients with chronic hepatitis B virus infection receiving nucleos(t)ide analogue therapy: an analysis using a Markov chain model.
    Eur J Gastroenterol Hepatol. 2019 May 6. doi: 10.1097/MEG.0000000000001434.
    PubMed     Text format     Abstract available

  10. COSTA M, Rojas Rojas T, Lacoste D, Villes V, et al
    Sleep disturbances in HIV-HCV coinfected patients: indications for clinical management in the HCV cure era (ANRS CO13 HEPAVIH cohort).
    Eur J Gastroenterol Hepatol. 2019 May 14. doi: 10.1097/MEG.0000000000001441.
    PubMed     Text format     Abstract available


    Gastroenterology

  11. WING PAC, Jones M, Cheung M, DaSilva S, et al
    Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir.
    Gastroenterology. 2019 May 9. pii: S0016-5085(19)40865.
    PubMed     Text format     Abstract available

  12. SINGAL AG, Rich NE, Mehta N, Branch A, et al
    Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30057.
    PubMed     Text format     Abstract available


    Gut

  13. HERZOG K, Bandiera S, Pernot S, Fauvelle C, et al
    Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity.
    Gut. 2019 May 10. pii: gutjnl-2018-317423. doi: 10.1136/gutjnl-2018-317423.
    PubMed     Text format     Abstract available


    Hepatology

  14. LIN KY, Lin PH, Sun HY, Chen YT, et al
    Hepatitis E Virus Infections Among HIV-Positive Individuals During an Outbreak of Acute Hepatitis A in Taiwan.
    Hepatology. 2019 May 17. doi: 10.1002/hep.30771.
    PubMed     Text format     Abstract available

  15. SUTHERLAND N, Li Wai Suen CFD, Mills C, Lokan J, et al
    Fibrosing cholestatic hepatitis-like syndrome in an immunocompetent patient with an acute flare of chronic hepatitis B.
    Hepatology. 2019 May 11. doi: 10.1002/hep.30763.
    PubMed     Text format     Abstract available


    J Hepatol

  16. KONIG A, Yang J, Jo E, Park KHP, et al
    Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
    J Hepatol. 2019 May 8. pii: S0168-8278(19)30271.
    PubMed     Text format     Abstract available

  17. ALAVI M, Law MG, Valerio H, Grebely J, et al
    Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    J Hepatol. 2019 May 9. pii: S0168-8278(19)30275.
    PubMed     Text format     Abstract available

  18. JI F, Yeo YH, Wei MT, Ogawa E, et al
    Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
    J Hepatol. 2019 May 13. pii: S0168-8278(19)30279.
    PubMed     Text format     Abstract available

  19. EVON DM, Sarkar S, Amador J, Lok AS, et al
    Patient-reported symptoms during and after direct acting antiviral therapies for chronic hepatitis C: The PROP UP Study.
    J Hepatol. 2019 May 13. pii: S0168-8278(19)30278.
    PubMed     Text format     Abstract available

  20. DIAS J, Hengst J, Parrot T, Leeansyah E, et al
    Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells.
    J Hepatol. 2019 May 6. pii: S0168-8278(19)30270.
    PubMed     Text format     Abstract available


    J Med Virol

  21. IFEORAH IM, Faleye TOC, Bakarey AS, Adewumi OM, et al
    Characterization of Hepatitis Delta Virus strains spreading in Abuja, Nigeria.
    J Med Virol. 2019 May 13. doi: 10.1002/jmv.25503.
    PubMed     Text format     Abstract available


    J Viral Hepat

  22. MORALES-ARRAEZ D, Alonso-Larruga A, Diaz-Flores F, Garcia Dopico JA, et al
    Predictive factors for not undergoing RNA testing in patients found to have hepatitis C serology and impact of an automatic alert.
    J Viral Hepat. 2019 May 11. doi: 10.1111/jvh.13122.
    PubMed     Text format     Abstract available

  23. VAN DAMME P, Dionne M, Leroux-Roels G, Van Der Meeren O, et al
    Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults.
    J Viral Hepat. 2019 May 14. doi: 10.1111/jvh.13125.
    PubMed     Text format     Abstract available

  24. ZHAO M, Zou H, Chen Y, Zheng S, et al
    Efficacy of antepartum administration of Hepatitis B immunoglobulin in preventing mother-to-child transmission of Hepatitis B virus.
    J Viral Hepat. 2019 May 14. doi: 10.1111/jvh.13123.
    PubMed     Text format     Abstract available

  25. NING Q, Wu D, Wang G, Ren H, et al
    Roadmap to Functional Cure of Chronic Hepatitis B: an expert consensus.
    J Viral Hepat. 2019 May 13. doi: 10.1111/jvh.13126.
    PubMed     Text format     Abstract available

  26. MOORE MS, Greene SK, Bocour A, Brown CM, et al
    Comprehensive nationwide chronic hepatitis C surveillance is necessary for accurate state-level prevalence estimates.
    J Viral Hepat. 2019 May 13. doi: 10.1111/jvh.13124.
    PubMed     Text format     Abstract available

  27. BERGLOV A, Hallager S, Weis N
    Hepatitis E during pregnancy: maternal and fetal case-fatality rates and adverse outcomes - a systematic review.
    J Viral Hepat. 2019 May 16. doi: 10.1111/jvh.13129.
    PubMed     Text format     Abstract available

  28. LHOMME S, Gallian P, Dimeglio C, Assal A, et al
    Viral load and clinical manifestations of hepatitis E virus genotype 3 infections.
    J Viral Hepat. 2019 May 16. doi: 10.1111/jvh.13128.
    PubMed     Text format     Abstract available


    J Virol

  29. DAS A, Maury W, Lemon SM
    TIM1 (HAVCR1): an Essential "Receptor" or an "Accessory Attachment Factor" for Hepatitis A Virus?
    J Virol. 2019;93.
    PubMed     Text format    

  30. COSTAFREDA MI, Kaplan G
    Reply to Das et al., "TIM1 (HAVCR1): an Essential 'Receptor' or an 'Accessory Attachment Factor' for Hepatitis A Virus?"
    J Virol. 2019;93.
    PubMed     Text format    


    JAMA

  31. MARKS K, Naggie S
    Management of Hepatitis C in 2019.
    JAMA. 2019 May 17. pii: 2734262. doi: 10.1001/jama.2019.5353.
    PubMed     Text format    


    PLoS One

  32. CHEN M, Ma Y, Chen H, Dai J, et al
    Complete genome sequencing and evolutionary analysis of HCV subtype 6xg from IDUs in Yunnan, China.
    PLoS One. 2019;14:e0217010.
    PubMed     Text format     Abstract available

  33. MANGIA A, Piazzolla V, Giannelli A, Visaggi E, et al
    SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.
    PLoS One. 2019;14:e0215783.
    PubMed     Text format     Abstract available


    PLoS Pathog

  34. KECK ZY, Pierce BG, Lau P, Lu J, et al
    Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design.
    PLoS Pathog. 2019;15:e1007772.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  35. SARRAZIN C, Buggisch P, Mauss S, Muller T, et al
    Evolution of HCV patient characteristics and DAA regimens in the German Hepatitis C Registry (DHC-R) in 2014 and 2015.
    Z Gastroenterol. 2019;57:584-592.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: